Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality

Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality

ObjectivesRituximab is a valuable agent for treating adult B-cell non-Hodgkin lymphoma (B-NHL), and several studies have tested its efficacy in children with mature, high-grade B-NHL. The aim of the present study was to systematically review the use of rituximab in children and adolescents with high...

Full description

Saved in:
Bibliographic Details
Main Authors: Alejandra Adriana Cardoso de Castro, Liana Alves de Oliveira, Diancarlos Pereira de Andrade, Edna Kakitani Carbone, Roberto Rosati
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pediatrics
Subjects:
rituximab
lymphoma
non-Hodgkin lymphoma
B cell lymphoma
pediatrics
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1532274/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items